Key facts
- Notable investors include Changxing Financial Holding, Huizhi Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for MINGZE PHARMA
- ·The full record, as it builds
Funding rounds
No funding rounds for MINGZE PHARMA are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About MINGZE PHARMA
Developer of pharmaceutical formulations designed to advance transdermal and topical drug delivery technologies. The company offers diversified research and development platforms covering transdermal patches, semi-solid formulations, and oral dosage forms, enabling pharmaceutical enterprises to accelerate drug development, achieve regulatory compliance, and enhance therapeutic efficacy.
- Sector
- Healthcare
- HQ
- Beijing, China
- Founded
- 2014
- Employees
- 18
- Website
- mingzezhonghe.com/
- Ownership
- Privately Held (backing)
MINGZE PHARMA doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in MINGZE PHARMA shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on MINGZE PHARMA in its N-PORT filings yet. We sweep new filings monthly.